Background Screening Table of Contents Instructions | Descriptions | More Information | Screening Criteria | Background Screening Appeal | Screening Provider | International Screening Information | ...

Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on ...